About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNCT04890444

China Adrenal Disease Registry

Epidemiologic studies have revealed a tremendous increase in the prevalence of adrenal associated disease and related mortality worldwide. In order to meet all the therapeutic challenges in adrenal di...

Lead sponsor: Shanghai Jiao Tong University School of Medicine•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

shouyue SUN, MD

CONTACT

18121263206 ssy10926@rjh.com.cn

Sponsors

Lead Sponsor

Shanghai Jiao Tong University School of Medicine

In order to meet all the challenges in the diagnosis and treatment of adrenal diseases in China, CASE was founded in 2020. With advanced medical equipment and Internet of Things (IoT) technology, CASE is committed to creating an online and offline integrated solution for adrenal disease, and for the entire spectrum of adrenal disease, to achieve a more convenient and precise model of care for patients, aiming to establish a platform with diagnosis and treatment of adrenal disease and their long-term follow-up. It allows the application and evaluation of treatment strategies at these centers.

Age

16 - 75 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Age ≥ 16 years old and ≤ 75 years
•2. Patients diagnosed with adrenal associated diseases, including cushing syndrome, primary aldosteronism, primary hypoadrenalism, congenital adrenal hyperplasia and adrenal adenomas, incidentalomas, and carcinomas, pheochromocytoma, etc.
•3. Provide written informed consent
•4. Satisfactory compliance

Exclusion Criteria

•1. Patients with significantly reduced life expectancy (less than 2 years)
•2. With Drug abuse
•3. With AIDS or syphilis or infectious diseases such as viral tuberculosis in active phase at enrollment

Related studies

Randomised Trial Comparing Thermal Ablation With Adrenalectomy in the Treatment of Unilateral Asymmetric PA

NCT05405101 · Primary Aldosteronism

68Ga-Pentixafor PET/CT Versus Adrenal Vein Sampling in Diagnosing Unilateral Subtype of Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion (PREDICT)

NCT06833437 · Primary Aldosteronism, Autonomous Cortisol Secretion

Prognosis of Primary Aldosteronism: A Prospective Cohort Study

NCT07378176 · Primary Aldosteronism

Steroids-Based Screening for Primary Aldosteronism

NCT06941116 · Primary Aldosteronism, Hypertension

Institutional Registry of Rare Diseases

NCT06573723 · Rare Diseases, Amyloidosis, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 14, 2022Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment2,000

Start dateJun 2021

Last updatedFeb 14, 2022

Condition

Cushing Syndrome Aldosteronism Hypoadrenalism Congenital Adrenal Hyperplasia Adrenal Adenoma+3 more

Locations shown

Endocrinology

Shanghai

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 14, 2022Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions